NO126366B - - Google Patents
Download PDFInfo
- Publication number
- NO126366B NO126366B NO00165751A NO16575166A NO126366B NO 126366 B NO126366 B NO 126366B NO 00165751 A NO00165751 A NO 00165751A NO 16575166 A NO16575166 A NO 16575166A NO 126366 B NO126366 B NO 126366B
- Authority
- NO
- Norway
- Prior art keywords
- group
- dien
- ethyl
- ether
- give
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- -1 ethylenedioxy Chemical group 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- 239000000203 mixture Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- IHLVCKWPAMTVTG-UHFFFAOYSA-N lithium;carbanide Chemical group [Li+].[CH3-] IHLVCKWPAMTVTG-UHFFFAOYSA-N 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 230000001817 pituitary effect Effects 0.000 description 3
- 230000001072 progestational effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- KFUSEUYYWQURPO-UPHRSURJSA-N cis-1,2-dichloroethene Chemical group Cl\C=C/Cl KFUSEUYYWQURPO-UPHRSURJSA-N 0.000 description 2
- 125000001240 enamine group Chemical group 0.000 description 2
- 230000001456 gonadotroph Effects 0.000 description 2
- 125000000232 haloalkynyl group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005907 ketalization reaction Methods 0.000 description 2
- OUIQXDUPDANAAW-UHFFFAOYSA-N lithium;chloroethyne Chemical compound [Li+].ClC#[C-] OUIQXDUPDANAAW-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011905 homologation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 238000011121 vaginal smear Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB32065/63A GB1100442A (en) | 1963-08-14 | 1963-08-14 | Gonadienones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126366B true NO126366B (de) | 1973-01-29 |
Family
ID=10332644
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO154277A NO125630B (de) | 1963-08-14 | 1964-08-05 | |
| NO00165751A NO126366B (de) | 1963-08-14 | 1966-11-25 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO154277A NO125630B (de) | 1963-08-14 | 1964-08-05 |
Country Status (12)
| Country | Link |
|---|---|
| AT (2) | AT292207B (de) |
| BE (1) | BE651798A (de) |
| BR (1) | BR6461644D0 (de) |
| CH (2) | CH518918A (de) |
| DE (1) | DE1468989C2 (de) |
| DK (1) | DK131114B (de) |
| ES (1) | ES303114A1 (de) |
| FR (2) | FR1447954A (de) |
| GB (1) | GB1100442A (de) |
| NL (1) | NL6409385A (de) |
| NO (2) | NO125630B (de) |
| SE (2) | SE328872B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012095644A1 (en) | 2011-01-12 | 2012-07-19 | Siemens Aktiengesellschaft | A compact, low energy neutron source |
-
0
- BE BE651798D patent/BE651798A/xx unknown
-
1963
- 1963-08-14 GB GB32065/63A patent/GB1100442A/en not_active Expired
-
1964
- 1964-08-05 NO NO154277A patent/NO125630B/no unknown
- 1964-08-10 BR BR161644/64A patent/BR6461644D0/pt unknown
- 1964-08-10 DE DE1468989A patent/DE1468989C2/de not_active Expired
- 1964-08-12 CH CH1053064A patent/CH518918A/de not_active IP Right Cessation
- 1964-08-12 CH CH663971A patent/CH540895A/de not_active IP Right Cessation
- 1964-08-13 AT AT762366A patent/AT292207B/de not_active IP Right Cessation
- 1964-08-13 DK DK400564AA patent/DK131114B/da unknown
- 1964-08-13 FR FR985157A patent/FR1447954A/fr not_active Expired
- 1964-08-13 AT AT697064A patent/AT267078B/de active
- 1964-08-13 ES ES0303114A patent/ES303114A1/es not_active Expired
- 1964-08-14 SE SE03944/68A patent/SE328872B/xx unknown
- 1964-08-14 SE SE09835/64A patent/SE330381B/xx unknown
- 1964-08-14 NL NL6409385A patent/NL6409385A/xx unknown
- 1964-11-12 FR FR994685A patent/FR4877M/fr not_active Expired
-
1966
- 1966-11-25 NO NO00165751A patent/NO126366B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE651798A (de) | |
| BR6461644D0 (pt) | 1973-08-07 |
| DK131114C (de) | 1975-10-27 |
| SE328872B (de) | 1970-09-28 |
| SE330381B (de) | 1970-11-16 |
| NO125630B (de) | 1972-10-09 |
| FR4877M (de) | 1967-03-06 |
| FR1447954A (fr) | 1966-08-05 |
| NL6409385A (de) | 1965-08-25 |
| CH540895A (de) | 1973-10-15 |
| AT267078B (de) | 1968-12-10 |
| DE1468989B1 (de) | 1973-10-25 |
| CH518918A (de) | 1972-02-15 |
| DK131114B (da) | 1975-05-26 |
| ES303114A1 (es) | 1965-02-01 |
| DE1468989C2 (de) | 1974-05-30 |
| GB1100442A (en) | 1968-01-24 |
| AT292207B (de) | 1971-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Colton et al. | 17-Alkyl-19-nortestosterones | |
| NO165753B (no) | Ceriumoksyd og fremgangsmaate for dets fremstilling. | |
| US4389345A (en) | 3-Oxoestra-17-acetonitrile and unsaturated analogs | |
| Romo et al. | Steroids. XX. 1a Cyclic Steroidal Hemithioketals1b | |
| US2697108A (en) | 16-thiobenzyl pregnenes and process | |
| NO164677B (no) | Fremgangsmaate for selektiv opprettelse av en fluidsperre. | |
| US3381003A (en) | 3-keto-13beta-alkyl-17beta-acetyl-gona-4-ene-17alpha-ol compounds and processes of preparing them | |
| NO126366B (de) | ||
| US3095412A (en) | 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs | |
| US3534139A (en) | 17alpha - ethynyl - 8alpha - h - delta**5(10) - estrene - 17beta - ol-3-one,process of preparation,therapeutic administration and intermediates | |
| US2855413A (en) | 16-haloestradiol esters and ethers | |
| US2875215A (en) | 1-acylthio substitution products of 3, 17-dioxygenated androstane derivatives | |
| US3480621A (en) | Steroid ketal | |
| US3636011A (en) | 11beta-fluoro-19-nor-steroids and process for their preparation | |
| US3442918A (en) | 17alpha-alka-1',3'-diynyl steroids | |
| US3290287A (en) | 17-oxygenated (optionally nu-alkylated) 2-azaandrostan-3-ones, 4-dehydro derivativesthereof, and alpha-homo compounds corresponding | |
| US3032552A (en) | 1-methyl steroids of the androstane series | |
| US3509135A (en) | 3-oxygenated 4'-5 - dihydrospiro(estra-4,9-diene-17,2'(3'h)-furans) and congeners | |
| US3052693A (en) | Steroid alkyl ethers and process therefor | |
| Klimstra et al. | Anabolic Agents. A-Ring Conjugated Enone Androstane Derivatives1a | |
| US2590637A (en) | Direct halogenation of steroids with an unsaturated side chain in 17-position and the dehydrohalogenation of resultant products | |
| US3351639A (en) | 17-alkyl-20-keto substituted pregnenes, pregnadienes and methods of preparing the same | |
| NO124598B (de) | ||
| US3299106A (en) | Process for the preparation of uncontaminated 17alpha-ethynyl-19-nor-delta4-androsten-17beta-ol-3-one | |
| US3629301A (en) | 3 3-difluoro-2-substituted steroids and their preparation |